The inhibition of DNMT1 using aurintricarboxylic acid was shown to result in reduced activity within the pancreatic β cells of T2DM mice, contributing to lowered blood glucose and improved insulin signaling, with this finding holding therapeutic promise for the treatment of diabetes (Chen, Liao, Tsai, & Tsai, 2016). Here, INS is linked to diabetes mellitus.